insights_auto
Nega EDIT tushdi 3,61%?
Batafsil oʻrganishchevron_right
EDIT:NASDAQ
Editas Medicine Inc
2,40 US$
arrow_downward
-3,61%(-0,090) 1K
23-okt, 16:00:00 (GMT-4) · USD
search
Barcha belgilar
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_autoEDIT tikeri uchun statistika yaratilmoqda...
Ochish
2,44 US$
Yuqori
2,45 US$
Past
2,30 US$
Bozor kapitali
368,59 mln
Oʻrtacha hajm
2,92 mln
Hajmi
0,00
52 haftalik eng yuqori
3,94 US$
52 haftalik eng past
1,66 US$
Aksiya boʻyicha daromad
-0,74 US$
Beta
2,00
Muomaladagi aksiyalar
153,58 mln
Xodimlar soni
87
Ochish
2,44 US$
Yuqori
2,45 US$
Past
2,30 US$
Bozor kapitali
368,59 mln
Oʻrtacha hajm
2,92 mln
Hajmi
0,00
52 haftalik eng yuqori
3,94 US$
52 haftalik eng past
1,66 US$
Aksiya boʻyicha daromad
-0,74 US$
Beta
2,00
Muomaladagi aksiyalar
153,58 mln
Xodimlar soni
87
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
TradingView
·
1 soat oldin
Stock Market: Will S&P 500 Open Up or Down Today?
Benzinga
·
17 daqiqa oldin
Dow Tumbles Over 1% as Oil Prices Rise: Greed Index Remains in ‘Extreme Fear’ Zone
Bloomberg.com
·
17 soat oldin
Zero-Day Option Traders Are Betting Against Big S&P 500 Swings
MarketWatch
·
17 soat oldin
More than a third of S&P 500 companies are about to report earnings as market confidence cracks
Profil
Editas Medicine, Inc., is a clinical-stage biotechnology company which is developing therapies for rare diseases based on CRISPR gene editing technology. Editas headquarters is located in Cambridge, Massachusetts and has facilities in Boulder, Colorado. Wikipedia
Editas Medicine Inc haqida